标题
The Impact of Type 2 Diabetes in Parkinson's Disease
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-06-14
DOI
10.1002/mds.29122
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
- (2021) Harneek Chohan et al. MOVEMENT DISORDERS
- Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson’s disease
- (2021) Seong Ho Jeong et al. BRAIN
- Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease
- (2021) Mingcui Zheng et al. 3 Biotech
- Effect of diabetes control status on the progression of Parkinson’s disease: A prospective study
- (2021) Ruwei Ou et al. Annals of Clinical and Translational Neurology
- Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein
- (2021) Ivan Martinez-Valbuena et al. Acta Neuropathologica Communications
- Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study
- (2021) Kathleen T. Watson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neuropathological evidence of body-first vs. brain-first Lewy body disease
- (2021) Per Borghammer et al. NEUROBIOLOGY OF DISEASE
- Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance
- (2020) Carla Nasca et al. MOLECULAR PSYCHIATRY
- Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study
- (2020) Jacob Horsager et al. BRAIN
- Association of Insulin Resistance With Depression Severity and Remission Status
- (2020) Kathleen T. Watson et al. JAMA Psychiatry
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
- (2019) Natalia de M. Lyra e Silva et al. Frontiers in Psychiatry
- Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
- (2018) Ivan Martinez-Valbuena et al. ACTA NEUROPATHOLOGICA
- Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
- (2018) Katelyn Becker et al. MOLECULAR NEUROBIOLOGY
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Association between diabetes and subsequent Parkinson disease
- (2018) Eduardo De Pablo-Fernandez et al. NEUROLOGY
- Insulin resistance, an unmasked culprit in depressive disorders: Promises for interventions
- (2018) Kathleen Watson et al. NEUROPHARMACOLOGY
- Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson’s disease
- (2018) Sathiya Sekar et al. NEUROSCIENCE LETTERS
- Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
- (2018) Seok Jong Chung et al. PARKINSONISM & RELATED DISORDERS
- Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson’s disease
- (2018) Raymond S. Schwartz et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
- (2018) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Age and time course of long-term motor and nonmotor complications in Parkinson disease
- (2018) Stéphane Prange et al. NEUROLOGY
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study
- (2017) Anders Bjornestad et al. PARKINSONISM & RELATED DISORDERS
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- The Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability
- (2016) Joni S. Williams et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease
- (2016) Istvan Horvath et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Too many covariates and too few cases? - a comparative study
- (2016) Qingxia Chen et al. STATISTICS IN MEDICINE
- Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study
- (2016) C.D. Moulton et al. Primary Care Diabetes
- Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans
- (2015) F. Caravaggio et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Type 2 diabetes as a protein misfolding disease
- (2015) Abhisek Mukherjee et al. TRENDS IN MOLECULAR MEDICINE
- Tracking Parkinson’s: Study Design and Baseline Patient Data
- (2015) Naveed Malek et al. Journal of Parkinsons Disease
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
- (2014) B I Pérez-Revuelta et al. Cell Death & Disease
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease
- (2013) Vikas Kotagal et al. PARKINSONISM & RELATED DISORDERS
- Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
- (2013) Jose A. Santiago et al. PLoS One
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults
- (2012) C. M. Falvey et al. DIABETES CARE
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- The natural history of treated Parkinson's disease in an incident, community based cohort
- (2011) J. R. Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Methods of Covariate Selection: Directed Acyclic Graphs and the Change-in-Estimate Procedure
- (2009) H.-Y. Weng et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease
- (2009) Daniel Weintraub et al. MOVEMENT DISORDERS
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
- (2009) S. Hoops et al. NEUROLOGY
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
- (2008) Linda B. Moran et al. NEUROGENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now